Review and evaluate the role of a psychiatric pharmacist on medication management in a Gender Health Program

被引:2
|
作者
Wartman, Carolanne [1 ,2 ]
Walroth, Todd A. [1 ,2 ]
Butterfield, David [1 ,2 ]
Anderson, Lindsey [1 ,2 ]
Peters, Michael [1 ]
Schmelz, Andrew [1 ,3 ]
Ott, Carol [1 ,2 ,4 ]
机构
[1] Eskenazi Hlth, Dept Pharm, Indianapolis, IN 46202 USA
[2] Purdue Univ, Coll Pharm, Dept Pharm Practice, W Lafayette, IN 47907 USA
[3] Butler Univ, Dept Pharm Practice, Coll Pharm, Indianapolis, IN 46208 USA
[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
关键词
mental health; pharmacists; psychiatry; transgender persons;
D O I
10.1002/jac5.1722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction People who identify as transgender experience a significant amount of mental health concerns compared to the general population. Gender health programs offer the opportunity to provide comprehensive care for this highly stigmatized population, with the potential for psychiatric pharmacists to assist other providers and serve this need. This study aimed to evaluate the number and type of interventions made by a psychiatric pharmacist within a Gender Health Program. Methods A retrospective review of the electronic medical record was conducted analyzing mental health visits completed by psychiatric pharmacists within the Gender Health Program between May 1, 2020 and December 31, 2021. The primary outcome was number and type of interventions, defined as medication adjustments, laboratory monitoring, and completion of prior authorizations. Secondary outcomes included a description of medication regimens, number and type of patient education provided, and referrals to other healthcare professionals. Key subgroup analyses consisted of number of interventions based on gender identity, race identity, and insurance status. Results There were a total of 152 appointments among 93 patients. Sixty-one patients (66%) received at least one intervention [median (interquartile range, IQR) of 2 (2, 4)], which occurred across 81 pharmacist appointments (53%). Psychotropic medications were adjusted at 79 appointments (97%), with primarily medication initiations. Patient education was completed and documented at 102 appointments with a median (IQR) of 2 (1, 2) topics discussed per appointment. There was a statistically significant difference found between transmen and transwomen on number of interventions [31 (67%) vs 15 (45%), P = 0.048]. Conclusion The pharmacist in this study had the opportunity to bridge gaps in access to care to healthcare providers by initiating and managing medications, providing thorough education, and referring patients to further resources. This study affirms the accessibility and role of a psychiatric pharmacist on the interdisciplinary team caring for lesbian, gay, bisexual, transgender, queer or questioning, and more (LGBTQ+) patients.
引用
下载
收藏
页码:1278 / 1283
页数:6
相关论文
共 50 条
  • [21] Development and implementation of a pharmacist-run comprehensive medication review program in Wisconsin
    Schoenrock, Danielle L.
    Hartkopf, Katherine
    Boeckelman, Carrie
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (23) : S155 - S160
  • [22] Gender Differences in Medication Management Capacity in HIV Infection: The Role of Health Literacy and Numeracy
    Drenna Waldrop-Valverde
    Deborah L. Jones
    Dushyantha Jayaweera
    Peggy Gonzalez
    Javier Romero
    Raymond L. Ownby
    AIDS and Behavior, 2009, 13 : 46 - 52
  • [23] Gender Differences in Medication Management Capacity in HIV Infection: The Role of Health Literacy and Numeracy
    Waldrop-Valverde, Drenna
    Jones, Deborah L.
    Jayaweera, Dushyantha
    Gonzalez, Peggy
    Romero, Javier
    Ownby, Raymond L.
    AIDS AND BEHAVIOR, 2009, 13 (01) : 46 - 52
  • [24] Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice
    Axon, David R.
    Kloster, Jim
    Eckert, Becka
    Morales, Sonia
    Riggs, Sally
    Kilungo, Aminata
    Ehiri, John
    Grieser, Megan
    Turner-Warren, Tenneh
    Aseret-Manygoats, Teresa
    Bingham, Jennifer M.
    Scovis, Nicole
    Warholak, Terri
    CLINICS AND PRACTICE, 2022, 12 (03) : 243 - 252
  • [25] The Role of the Community Pharmacist in Detecting and Decreasing Medication Errors: A Scoping Review
    Onatibia-Astibia, Ainhoa
    Aizpurua-Arruti, Xabier
    Malet-Larrea, Amaia
    Angel Gastelurrutia, Miguel
    Goyenechea, Estibaliz
    ARS PHARMACEUTICA, 2021, 62 (01) : 15 - 39
  • [26] Uptake of Pharmacist Recommendations After Pharmacist-led Medication Management and Polypharmacy Review for Older Adults
    Julien, D.
    Kemp, L.
    Manns, K.
    Vandenberg, A.
    Mirk, A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S119 - S119
  • [28] Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the Elderly
    Caffiero, Nicole
    Delate, Thomas
    Ehizuelen, Mercy D.
    Vogel, Kris
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (05): : 525 - 531
  • [29] Peripartum mental health and the role of the pharmacist: A scoping review
    Urslak, Randilynne
    Evans, Charity
    Nakhla, Nardine
    Marrie, Ruth Ann
    McConnell, Brie M.
    Maxwell, Colleen J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (09): : 1243 - 1255
  • [30] IMPACT OF A PHARMACIST-BASED DIABETES MANAGEMENT PROGRAM ON ADHERENCE TO MEDICATION FOR DIABETIC PATIENTS
    Agrawal, R.
    Sansgiry, S.
    Patel, H.
    Hayes, D.
    Roberson, K.
    James, C.
    VALUE IN HEALTH, 2011, 14 (03) : A101 - A101